|2.73||-0.03 / -1.09%|
Data as of 3:59pm ET
|2.70||-0.03 / -1.10%|
The 2 analysts offering 12-month price forecasts for CytRx Corp have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +302.93% increase from the last price of 2.73.
The current consensus among 2 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.